REGN-7257

N/A

Report date: 2025/09/06 20:00:11

Base Information

Drug NameREGN-7257
Drug Alias NameREGN-7257
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Interleukin-2 receptor subunit gamma
TargetsInterleukin-2 receptor subunit gamma
Therapy Area/IndicationsAnemia, Aplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomFrance +[4
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAnemia, Aplastic

Other Information

ATC CodeN/A
Related LinksN/A